Dionex Corporation (DNEX) announced that Dr. Frank Witney will become its President, Chief Executive Officer and a member of its Board of Directors, effective April 30, 2009. Dr. Lukas Braunschweiler, who has been serving as President and Chief Executive Officer since 2002, resigned in order to accept a new position as Chief Executive Officer of Ruag Holding AG, a Switzerland-based aviation, defense and technology company.
Dr. Witney joins Dionex from Affymetrix, Inc. (AFFX) where he served as Executive Vice President and Chief Commercial Officer. He served as President and Chief Executive Officer of Panomics, Inc. (formerly Genospectra, Inc.) from July 2002 to December 2008. Prior to joining Panomics, Dr. Witney was President of Drug Discovery Tools at PerkinElmer Life Sciences. He assumed this position after PerkinElmer's acquisition of Packard BioScience Company, where he was President and Chief Operating Officer. From 1983 through 2000, Dr. Witney held a series of management positions at Bio-Rad Laboratories, most recently as Group Operations Manager of the Life Science Group.
KNOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.
ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.
If your company wishes to participate in the EventX newswire, please contact Knobias: http://www.knobias.com
Knobias.com, LLC 601-978-3399 601-978-3675 info@knobias.com www.knobias.com/cmtx

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index